← Back to Clinical Trials
Recruiting NCT06402409

NCT06402409 Exploring Multimorbidity in Patients With Spinal Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06402409
Status Recruiting
Phase
Sponsor Jacob Christiansen Gandløse
Condition Back Pain
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2024-04-01
Primary Completion 2026-10-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2024-04-01 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Spinal pain is frequently accompanied by other chronic conditions (multimorbidity) and the predicted rise in multimorbidity prevalence emphasizes the need for studies to understand its impact on patients with chronic pain conditions. Therefore the aims of the two studies are to: Work package 1 - Determine prevalence of multimorbidity among patients with spinal pain referred to hospital outpatient clinics. Examine associations with relevant health-related factors and cover the significance of multimorbidity in the diagnostic process, referral patterns and healthcare utilization. Work package 2: Examine the association between treatment burden arising from multimorbidity and patient prognosis in structured rehabilitation. Across both work packages data will be derived from individuals initially referred to the Department of Rheumatology at Aalborg University Hospital (AaUH) or the Medical Spine Clinic in Silkeborg (MSCS).

Eligibility Criteria

Inclusion Criteria: * 18 years old or above * Are diagnosed with neck or back pain * Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion) * Speak, read and understand Danish Exclusion Criteria: * Withdraw consent

Contact & Investigator

Central Contact

Jacob Gandløse, PhD Student

✉ j.gandloese@rn.dk

📞 50998483

Frequently Asked Questions

Who can join the NCT06402409 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06402409 currently recruiting?

Yes, NCT06402409 is actively recruiting participants. Contact the research team at j.gandloese@rn.dk for enrollment information.

Where is the NCT06402409 trial being conducted?

This trial is being conducted at Aalborg, Denmark.

Who is sponsoring the NCT06402409 clinical trial?

NCT06402409 is sponsored by Jacob Christiansen Gandløse. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology